JP2010540677A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540677A5 JP2010540677A5 JP2010528477A JP2010528477A JP2010540677A5 JP 2010540677 A5 JP2010540677 A5 JP 2010540677A5 JP 2010528477 A JP2010528477 A JP 2010528477A JP 2010528477 A JP2010528477 A JP 2010528477A JP 2010540677 A5 JP2010540677 A5 JP 2010540677A5
- Authority
- JP
- Japan
- Prior art keywords
- electron withdrawing
- site
- polymer
- group
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 5
- 125000006575 electron-withdrawing group Chemical group 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- 125000005647 linker group Chemical group 0.000 claims description 3
- 229920002704 polyhistidine Polymers 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 125000004450 alkenylene group Chemical group 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07253992.7 | 2007-10-09 | ||
| EP07253992 | 2007-10-09 | ||
| GB0813339A GB0813339D0 (en) | 2008-07-21 | 2008-07-21 | Novel reagents and method for conjugating biological molecules |
| GB0813339.9 | 2008-07-21 | ||
| PCT/GB2008/003409 WO2009047500A1 (en) | 2007-10-09 | 2008-10-08 | Novel conjugated proteins and peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016040039A Division JP6250083B2 (ja) | 2007-10-09 | 2016-03-02 | 新規な複合タンパク質及びペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010540677A JP2010540677A (ja) | 2010-12-24 |
| JP2010540677A5 true JP2010540677A5 (enExample) | 2016-04-28 |
| JP5933923B2 JP5933923B2 (ja) | 2016-06-22 |
Family
ID=40225449
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010528477A Expired - Fee Related JP5933923B2 (ja) | 2007-10-09 | 2008-10-08 | 新規な複合タンパク質及びペプチド |
| JP2016040039A Expired - Fee Related JP6250083B2 (ja) | 2007-10-09 | 2016-03-02 | 新規な複合タンパク質及びペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016040039A Expired - Fee Related JP6250083B2 (ja) | 2007-10-09 | 2016-03-02 | 新規な複合タンパク質及びペプチド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100239517A1 (enExample) |
| EP (1) | EP2209494B1 (enExample) |
| JP (2) | JP5933923B2 (enExample) |
| KR (1) | KR20100090684A (enExample) |
| CN (1) | CN101820920B (enExample) |
| BR (1) | BRPI0818288A2 (enExample) |
| DK (1) | DK2209494T3 (enExample) |
| ES (1) | ES2597849T3 (enExample) |
| WO (1) | WO2009047500A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0316294D0 (en) | 2003-07-11 | 2003-08-13 | Polytherics Ltd | Conjugated biological molecules and their preparation |
| ES2521490T3 (es) | 2006-12-15 | 2014-11-12 | Baxter International Inc. | Conjugado de factor VIIa - ácido (poli)siálico con una vida media in vivo prolongada. |
| KR101763559B1 (ko) | 2008-07-21 | 2017-08-14 | 폴리테릭스 리미티드 | 생물학적 분자의 컨쥬게이팅을 위한 신규한 시약 및 방법 |
| EP2350118B1 (en) | 2008-09-19 | 2016-03-30 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
| WO2010033217A1 (en) | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of cd-np peptides |
| GB0922354D0 (en) | 2009-12-21 | 2010-02-03 | Polytherics Ltd | Novel polymer conjugates |
| WO2010100430A1 (en) | 2009-03-04 | 2010-09-10 | Polytherics Limited | Conjugated proteins and peptides |
| GB0912485D0 (en) | 2009-07-17 | 2009-08-26 | Polytherics Ltd | Improved conjugation method |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| AU2010277438B2 (en) | 2009-07-27 | 2015-08-20 | Baxalta GmbH | Glycopolysialylation of non-blood coagulation proteins |
| PT2459224T (pt) | 2009-07-27 | 2016-09-05 | Baxalta Inc | Conjugados proteicos para coagulação sanguínea |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| SG178141A1 (en) | 2009-07-27 | 2012-03-29 | Baxter Int | Blood coagulation protein conjugates |
| ES2617713T3 (es) * | 2009-10-29 | 2017-06-19 | Korea Advanced Institute Of Science And Technology | Conjugados de derivado de polietilenglicol, catecol y proteína o péptido, y procedimiento de preparación de los mismos |
| GB201007356D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIIa |
| GB201007357D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIII |
| WO2012087838A1 (en) | 2010-12-22 | 2012-06-28 | Baxter International Inc. | Materials and methods for conjugating a water soluble fatty acid derivative to a protein |
| JP6202707B2 (ja) * | 2011-10-13 | 2017-09-27 | 国立大学法人鳥取大学 | 新規細胞膜透過ペプチド |
| US20150086524A1 (en) | 2012-04-16 | 2015-03-26 | Cantab Biopharmaceuticals Patents Limited | Optimised subcutaneous therapeutic agents |
| GB201210770D0 (en) | 2012-06-18 | 2012-08-01 | Polytherics Ltd | Novel conjugation reagents |
| US9650331B2 (en) | 2012-06-18 | 2017-05-16 | Polytherics Limited | Conjugation reagents |
| US9441010B2 (en) * | 2012-08-08 | 2016-09-13 | Clarkson University | Method for selective derivatization of oligohistidine sequence of recombinant proteins |
| ES2885854T3 (es) | 2014-10-14 | 2021-12-15 | Polytherics Ltd | Proceso para la conjugación de un péptido o proteína con un reactivo que comprende un grupo saliente que incluye una porción de PEG |
| US10098960B2 (en) | 2015-04-03 | 2018-10-16 | Ucl Business Plc | Polymer conjugate |
| US10975161B2 (en) | 2016-01-12 | 2021-04-13 | Crescendo Biologics Limited | Molecules that bind prostate specific membrane antigen (PSMA) |
| WO2017161206A1 (en) | 2016-03-16 | 2017-09-21 | Halozyme, Inc. | Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use |
| WO2017178828A1 (en) | 2016-04-14 | 2017-10-19 | Polytherics Limited | Conjugates and conjugating reagents comprising a linker that includes at least two (-ch2-ch2-0-) units in a ring |
| GB201608936D0 (en) | 2016-05-20 | 2016-07-06 | Polytherics Ltd | Novel conjugates and novel conjugating reagents |
| ES2965349T3 (es) | 2016-06-06 | 2024-04-12 | Abzena Uk Ltd | Anticuerpos, usos de los mismos y conjugados de los mismos |
| GB201614162D0 (en) | 2016-08-18 | 2016-10-05 | Polytherics Ltd | Antibodies, uses thereof and conjugates thereof |
| DE102017103050B4 (de) * | 2017-02-15 | 2019-05-16 | Hoerbiger Automatisierungstechnik Holding Gmbh | Fahrwerk einer transportablen Einrichtung |
| GB201711068D0 (en) | 2017-07-10 | 2017-08-23 | Crescendo Biologics Ltd | Therapeutic molecules binding PSMA |
| WO2020188323A1 (en) * | 2019-03-18 | 2020-09-24 | Khashayar Karimian | Mate and separate: a convenient and general method for the separation and purification of target molecules from biological media by phase transition of pegylated recognition agents. |
| EP4355371A1 (en) * | 2021-06-17 | 2024-04-24 | Nektar Therapeutics | Histidine-selective polymer reagents |
| WO2023166318A2 (en) | 2022-03-03 | 2023-09-07 | Cambridge Enterprise Limited | Therapeutic antibodies |
| EP4556907A1 (en) * | 2023-11-20 | 2025-05-21 | Miltenyi Biotec B.V. & Co. KG | Site-specific conjugation of single domain antibody fragments (vhh) using equilibrium transfer alkylation reagent (etac) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340522C (en) * | 1987-03-10 | 1999-05-04 | Heinz Dobeli | Fusion proteins containing neighbouring histidines for improved purification |
| US6552170B1 (en) * | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| EP0991944B1 (en) * | 1997-06-25 | 2004-08-25 | N.V. Innogenetics S.A. | Methods for covalent immobilisation of biomolecules to a carrier by means of a his-tag |
| US5985263A (en) * | 1997-12-19 | 1999-11-16 | Enzon, Inc. | Substantially pure histidine-linked protein polymer conjugates |
| FR2778918B1 (fr) * | 1998-05-25 | 2000-07-21 | Commissariat Energie Atomique | Baton moleculaire et ses applications |
| PL206536B1 (pl) * | 1998-10-16 | 2010-08-31 | Biogen Idec Inc | Kompozycja, kompozycja farmaceutyczna glikozylowanego interferonu-beta-1a, zastosowanie kompozycji glikozylowanego interferonu-beta-1a, sposób in vitro przedłużania aktywności glikozylowanego interferonu-beta-1a |
| GB0316294D0 (en) * | 2003-07-11 | 2003-08-13 | Polytherics Ltd | Conjugated biological molecules and their preparation |
-
2008
- 2008-10-08 JP JP2010528477A patent/JP5933923B2/ja not_active Expired - Fee Related
- 2008-10-08 EP EP08806549.5A patent/EP2209494B1/en not_active Not-in-force
- 2008-10-08 DK DK08806549.5T patent/DK2209494T3/en active
- 2008-10-08 BR BRPI0818288 patent/BRPI0818288A2/pt not_active Application Discontinuation
- 2008-10-08 US US12/682,057 patent/US20100239517A1/en not_active Abandoned
- 2008-10-08 KR KR1020107010204A patent/KR20100090684A/ko not_active Ceased
- 2008-10-08 CN CN200880110579.XA patent/CN101820920B/zh not_active Expired - Fee Related
- 2008-10-08 ES ES08806549.5T patent/ES2597849T3/es active Active
- 2008-10-08 WO PCT/GB2008/003409 patent/WO2009047500A1/en not_active Ceased
-
2016
- 2016-03-02 JP JP2016040039A patent/JP6250083B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010540677A5 (enExample) | ||
| JP2012021003A5 (enExample) | ||
| JP2011525509A5 (enExample) | ||
| JP2020500178A5 (enExample) | ||
| JP2012505871A5 (enExample) | ||
| JP2010536766A5 (enExample) | ||
| WO2009122044A3 (fr) | Complexes de bore ou d'aluminium | |
| JP2004524340A5 (enExample) | ||
| CY1118239T1 (el) | Πυραζολο[1,5-α]πυριμιδινες και -τριαζινες ως αντι-ιικοι παραγοντες | |
| JP2009530489A5 (enExample) | ||
| RU2013127187A (ru) | Терапевтическое применение соединений | |
| JP2011529073A5 (enExample) | ||
| EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
| JP2009535358A5 (enExample) | ||
| CY1108729T1 (el) | 3,11b-cis-διυδpotetpabenazinh για την θεραπευτικη αντιμετωπιση μιας πολλαπλασιαστικης νοσου ή φλεγμονωδους παθησης | |
| JP2009541414A5 (enExample) | ||
| JP2010079247A5 (enExample) | ||
| JP2009001551A5 (enExample) | ||
| JP2007119504A5 (enExample) | ||
| JP2010520851A5 (enExample) | ||
| JP2021504302A5 (enExample) | ||
| JP2007532575A5 (enExample) | ||
| JP2005527479A5 (enExample) | ||
| JP2009001552A5 (enExample) | ||
| JP2008260517A5 (enExample) |